AAAAAA

   
Results: 1-25 | 26-50 | 51-68
Results: 26-50/68
Pharmacokinetics of oral cyclosporin A when co-administered to enhance theabsorption of orally administered docetaxel
Authors: Malingre, MM Huinink, WWT Mackay, M Schellens, JHM Beijnen, JH
Citation: Mm. Malingre et al., Pharmacokinetics of oral cyclosporin A when co-administered to enhance theabsorption of orally administered docetaxel, EUR J CL PH, 57(4), 2001, pp. 305-307
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues
Authors: Maliepaard, M Scheffer, GL Faneyte, IF van Gastelen, MA Pijnenborg, ACLM Schinkel, AH van de Vijver, MJ Scheper, RJ Schellens, JHM
Citation: M. Maliepaard et al., Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues, CANCER RES, 61(8), 2001, pp. 3458-3464
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
Authors: Malingre, MM Beijnen, JH Rosing, H Koopman, FJ Jewell, RC Paul, EM Huinink, WWT Schellens, JHM
Citation: Mm. Malingre et al., Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients, BR J CANC, 84(1), 2001, pp. 42-47
Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan
Authors: Jonker, JW Smit, JW Brinkhuis, RF Maliepaard, M Beijnen, JH Schellens, JHM Schinkel, AH
Citation: Jw. Jonker et al., Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan, J NAT CANC, 92(20), 2000, pp. 1651-1656
High-performance liquid chromatographic methods for the determination of anovel polymer-bound paclitaxel derivative and free paclitaxel in human plasma
Authors: Terwogt, JMM Rosing, H Rocchetti, M Frigerio, E Fraier, D Koopman, FJ Schellens, JHM Huinink, WWT Beijnen, JH
Citation: Jmm. Terwogt et al., High-performance liquid chromatographic methods for the determination of anovel polymer-bound paclitaxel derivative and free paclitaxel in human plasma, J LIQ CHR R, 23(8), 2000, pp. 1233-1251
Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study
Authors: van Kesteren, C Cvitkovic, E Taamma, A Lopez-Lazaro, L Jimeno, JM Guzman, C Mathot, RAA Schellens, JHM Misset, JL Brain, E Hillebrand, MJX Rosing, H Beijnen, JH
Citation: C. Van Kesteren et al., Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study, CLIN CANC R, 6(12), 2000, pp. 4725-4732
Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein
Authors: Bardelmeijer, HA Beijnen, JH Brouwer, KR Rosing, H Nooijen, WJ Schellens, JHM van Tellingen, O
Citation: Ha. Bardelmeijer et al., Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein, CLIN CANC R, 6(11), 2000, pp. 4416-4421
Cyclosporine-induced anaphylaxis
Authors: Kuiper, RAJ Malingre, MM Beijnen, JH Schellens, JHM
Citation: Raj. Kuiper et al., Cyclosporine-induced anaphylaxis, ANN PHARMAC, 34(7-8), 2000, pp. 858-861
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients
Authors: Terwogt, JMM van Tellingen, O Panday, VRN Huizing, MT Schellens, JHM Huinink, WWT Boschma, MUS Giaccone, G Veenhof, CHN Beijnen, JH
Citation: Jmm. Terwogt et al., Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients, ANTI-CANC D, 11(9), 2000, pp. 687-694
Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: Results of a compassionate use program inThe Netherlands
Authors: Kruijtzer, CMF Verweij, J Schellens, JHM Beijnen, JH Pronk, L Bo, M Lustig, V van Tinteren, H Mackay, M Huinink, WWT
Citation: Cmf. Kruijtzer et al., Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: Results of a compassionate use program inThe Netherlands, ANTI-CANC D, 11(4), 2000, pp. 249-255
Pharmaceutical development of anticancer agents derived from marine sources
Authors: Nuijen, B Bouma, M Manada, C Jimeno, JM Schellens, JHM Bult, A Beijnen, JH
Citation: B. Nuijen et al., Pharmaceutical development of anticancer agents derived from marine sources, ANTI-CANC D, 11(10), 2000, pp. 793-811
Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration
Authors: Malingre, MM Schellens, JHM van Tellingen, O Rosing, H Koopman, FJ Duchin, K Huinink, WWT Swart, M Beijnen, JH
Citation: Mm. Malingre et al., Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration, ANTI-CANC D, 11(10), 2000, pp. 813-820
Validated method for the determination of platinum from a liposomal source(SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry
Authors: Terwogt, JMM Tibben, MM Welbank, H Schellens, JHM Beijnen, JH
Citation: Jmm. Terwogt et al., Validated method for the determination of platinum from a liposomal source(SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry, FRESEN J AN, 366(3), 2000, pp. 298-302
Modulation of oral bioavailability of anticancer drugs: from mouse to man
Authors: Schellens, JHM Malingre, MM Kruijtzer, CMF Bardelmeijer, HA van Tellingen, O Schinkel, AH Beijnen, JH
Citation: Jhm. Schellens et al., Modulation of oral bioavailability of anticancer drugs: from mouse to man, EUR J PH SC, 12(2), 2000, pp. 103-110
Phase I and pharmacokinetic study of oral paclitaxel
Authors: Malingre, MM Terwogt, JMM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., Phase I and pharmacokinetic study of oral paclitaxel, J CL ONCOL, 18(12), 2000, pp. 2468-2475
Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma) - A case report and review of the literature
Authors: Kruijtzer, CMF Beijnen, JH Swart, M Schellens, JHM
Citation: Cmf. Kruijtzer et al., Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma) - A case report and review of the literature, CANC CHEMOT, 45(5), 2000, pp. 428-431
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion
Authors: Rosing, H Lustig, V van Warmerdam, LJC Huizing, MT Huinink, WWT Schellens, JHM Rodenhuis, S Bult, A Beijnen, JH
Citation: H. Rosing et al., Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion, CANC CHEMOT, 45(3), 2000, pp. 213-218
Pharmacokinetically guided administration of chemotherapeutic agents
Authors: van den Bongard, HJGD Mathot, RAA Beijnen, JH Schellens, JHM
Citation: Hjgd. Van Den Bongard et al., Pharmacokinetically guided administration of chemotherapeutic agents, CLIN PHARMA, 39(5), 2000, pp. 345-367
Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM
Authors: Kerbusch, T Huitema, ADR Ouwerkerk, J Keizer, HJ Mathot, RAA Schellens, JHM Beijnen, JH
Citation: T. Kerbusch et al., Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM, BR J CL PH, 49(6), 2000, pp. 555-561
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery
Authors: Bardelmeijer, HA van Tellingen, O Schellens, JHM Beijnen, JH
Citation: Ha. Bardelmeijer et al., The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery, INV NEW DR, 18(3), 2000, pp. 231-241
Validation of techniques for the prediction of carboplatin exposure: Application of Bayesian methods
Authors: Huitema, ADR Mathot, RAA Tibben, MM Schellens, JHM Rodenhuis, S Beijnen, JH
Citation: Adr. Huitema et al., Validation of techniques for the prediction of carboplatin exposure: Application of Bayesian methods, CLIN PHARM, 67(6), 2000, pp. 621-630
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines
Authors: Scheffer, GL Maliepaard, M Pijnenborg, ACLM van Gastelen, MA de Jong, MC Schroeijers, AB van der Kolk, DM Allen, JD Ross, DD van der Valk, P Dalton, WS Schellens, JHM Scheper, RJ
Citation: Gl. Scheffer et al., Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines, CANCER RES, 60(10), 2000, pp. 2589-2593
Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
Authors: Rosing, H van Zomeren, DM Doyle, E Huinink, WWT Schellens, JHM Bult, A Beijnen, JH
Citation: H. Rosing et al., Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods, J CHROMAT B, 727(1-2), 1999, pp. 191-203
Coadministration of oral cyclosporin a enables oral therapy with paclitaxel
Authors: Terwogt, JMM Malingre, MM Beijnen, JH Huinink, WWT Rosing, H Koopman, FJ van Tellingen, O Swart, M Schellens, JHM
Citation: Jmm. Terwogt et al., Coadministration of oral cyclosporin a enables oral therapy with paclitaxel, CLIN CANC R, 5(11), 1999, pp. 3379-3384
A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (hycamtin)
Authors: Gerrits, CJH Schellens, JHM Burris, H Eckardt, JR Planting, AST van der Burg, MEL Rodriguez, GI Loos, WJ van Beurden, V Hudson, I Von Hoff, DD Verweij, J
Citation: Cjh. Gerrits et al., A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (hycamtin), CLIN CANC R, 5(1), 1999, pp. 69-75
Risultati: 1-25 | 26-50 | 51-68